News

Sirius Medical's Pintuition Achieves High Success Rate in Study

Sirius Medical's Pintuition Achieves High Success Rate in Study

Pintuition's Impact on Surgical Navigation

Sirius Medical has recently shared impressive outcomes from its extensive iBRA-NET study, showcasing the effectiveness of the Pintuition navigation system. This innovative technology presents a reliable alternative to traditional wire-guided localization for impalpable breast lesions.

Study Overview: A Landmark Analysis

The iBRA-NET study involved the largest international cohort to date, comprising 1,899 patients. Results indicated a remarkable 99.4% localization success rate for the Pintuition system, which aligns closely with the statistics from a traditional wire-based localization cohort of 1,170 patients. The data reflects significant merit in Pintuition's approach, particularly highlighting a reduced positive margin rate of 10.4%, as compared to 15.0% for wire-guided methods. This reduction signifies a critical advancement in patient outcomes, emphasizing the Pintuition's role in improving surgical precision.

Clinical Perspective on Navigation Solutions

Kitty Kempen, Director of Clinical & Medical Affairs at Sirius Medical, expressed enthusiasm over these findings, stating, "These results validate the clinical value of the Pintuition Surgical Marker Navigation, reinforcing our commitment to enhance surgical workflows and optimize patient experiences." The system embodies a GPS-like navigation platform designed to facilitate accurate tumor localization during breast-conserving surgical procedures.

Key Features of the Pintuition System

Pintuition's unique TargetLOC feature is particularly noteworthy; it signals surgeons when their probe is exactly positioned above the Pintuition marker. This functionality, paired with real-time audio and visual cues, enables unparalleled precision—overcoming some critical limitations that have historically plagued wire-based methods.

Insights from iBRA-NET Research Leads

Edward St John, Principal Investigator of the iBRA-NET study, highlighted the significance of this research, declaring, "The results of our study reveal that Surgical Marker Navigation utilizing Pintuition maintains non-inferiority compared to traditional wire localization techniques, offering substantial benefits for both patients and surgical teams."

Implications for Future Surgical Practices

The results from the iBRA-NET study were presented at the recent Association of Breast Surgery (ABS) Conference, further establishing the importance of the Pintuition system in surgical navigation. As the only prospective dataset currently comparing wire localization with a wireless alternative, these outcomes hint at a transformative shift in breast-conserving surgical methods.

A complete publication detailing the findings is anticipated to be released in the upcoming months, paving the way for broader acceptance and utilization of the Pintuition technology.

About the iBRA-NET Network

The iBRA-NET is a comprehensive network consisting of breast and plastic surgeons, allied healthcare professionals, and patients dedicated to evaluating new surgical techniques and enhancements in oncoplastic breast surgery. Their commitment to thorough assessments ensures innovation-driven advancements in patient care.

About Sirius Medical

Sirius Medical, rooted in the Netherlands Cancer Institute, is focused on elevating the standard of care for cancer patients through affordable surgical solutions. Their Pintuition technology is CE-marked and FDA-cleared, boasting an impressive track record with over 50,000 procedures performed across more than 250 centers worldwide, including a robust network spanning the USA, Western Europe, Australia, and New Zealand.

Media Contact:

Benjamin Tchang
Global Marketing Director
Sirius Medical
+31 647 852 805

Frequently Asked Questions

What is the Pintuition system?

The Pintuition system is a surgical navigation solution designed for precise tumor localization during breast-conserving surgeries.

What were the key findings of the iBRA-NET study?

The study revealed a 99.4% localization success rate for Pintuition and a significantly lower positive margin rate compared to traditional techniques.

Who presented the findings of the study?

Mr. Edward St John and Mr. Rajiv Dave were responsible for presenting the Pintuition results at the ABS Conference.

How does Pintuition compare to traditional wire localization?

Pintuition has been shown to be non-inferior to wire-based localization, underscoring its effectiveness and benefits.

What organizations support the iBRA-NET?

The iBRA-NET is endorsed by leading organizations such as the Association of Breast Surgery and the Royal College of Surgeons.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Synova Global Taps Eventus for Top Trade Surveillance

Updated Category News Views 144

Synova and Eventus: A Powerful Partnership If you've ever traded a share or two, you know the name of the game is risk management. Step into Synova Global's latest move, and you'll see a gamble worth watching closely. This time around, Synova has tapped Eventus to bring their Validus trade surveillance platform into the fold. Now, Eventus and its star player, Validus,...

Continue Reading
Cambiotics Launches Key Trial on Reducing PFAS in Firefighters

Updated Category News Views 44

Pioneering Efforts to Combat 'Forever Chemicals' Cambiotics is stepping into some uncharted territory—tackling the tricky problem of PFAS accumulation in firefighters. If you’ve been following this, PFAS, or per- and polyfluoroalkyl substances, have been living rent-free in our bodies for years. Used in firefighting equipment and foams, these chemicals stick around,...

Continue Reading
ZBS Group Takes Over Rabinowitz’s CPA Practice with Bold Moves

Updated Category News Views 44

Transitioning Power in the CPA World Let's cut to the chase—when a seasoned CPA like Joseph Rabinowitz picks up the phone to secure a succession partner, it's a big deal. Enter ZBS Group LLP, steered by Michael Zaidman, which isn't a stranger to these waters, undertaking their fourth CPA practice acquisition through Rabinowitz's corner of the accounting universe....

Continue Reading
Connecting NIH Data: Transforming Scientific Discoveries

Updated Category News Views 44

Rethinking How Research Data Drives Discovery When researchers generate truckloads of data, finding patterns that lead to breakthroughs often becomes a game of hide and seek. It's like having a jumbo puzzle with pieces scattered all over the place. Enter the NIH Common Fund Data Ecosystem—a game changer attempting to glue together these pieces across the research...

Continue Reading
Cerbo's AI Scribe Expands to Telehealth Success

Updated Category News Views 46

Cerbo Enhances Telehealth With AI Scribe Expansion The digital healthcare playground looks like it's getting a nudge toward efficiency with Cerbo's latest move. Just when you thought telehealth couldn't get much sharper, these folks have drawn a line in the sand with their AI Scribe, which now makes its presence felt in virtual visits. No more juggling a dozen screens...

Continue Reading
SportsMed Expands to 58 Clinics, New Opening in Jersey City

Updated Category News Views 28

SportsMed Physical Therapy Expands with New Clinic Well, here we are, talking about expansion. And not just any expansion—I'm talking about SportsMed Physical Therapy flexing its muscles in Jersey City Heights, boosting their count to 58 clinics scattered across New Jersey and Connecticut. It's like watching a network of care roots spreading deeper into the region, and...

Continue Reading
Geopolitical Talks Shake Oil Market, Refine Stocks' Path

Updated Category News Views 92

Diplomacy Takes Center Stage So here we are again, riding the rollercoaster of geopolitics that's jerking the oil market around like a marionette. With the U.S. and Iran allegedly chatting—mind you, with a ton of smoke and mirrors through Qatar and Islamabad—every trader's watching, hoping for a ceasefire that might either stabilize or further jolt energy prices. Oil...

Continue Reading
Linker Vision's AI Platform Boosts Urban Planning

Updated Category News Views 72

Now, I've seen a fair share of tech rollouts claiming to change the world, but Linker Vision’s new AI platform, Linker AI Nexa, might actually be onto something real here. Revealed at the Smart City Expo World Congress 2026 in Barcelona, this isn't just another pretty interface—it’s packing some serious firepower with NVIDIA tech. Bringing Physical AI to City...

Continue Reading
Bright Minds Faces Legal Scrutiny Over FDA Trial Hold

Updated Category News Views 72

Bright Minds Biosciences Under the Microscope Well, it looks like Bright Minds Biosciences has found itself in some hot water with investors. After the FDA put a partial hold on their Phase 2 trial for BMB-101, designed for epilepsy treatment, the stock took a nosedive. If you're holding a piece of NASDAQ:DRUG, or even if you cut your losses and ran, it's time to tune in....

Continue Reading
Instanodes Tackling Quantum Threats in Blockchain

Updated Category News Views 114

Diving Into Quantum Cryptography for Blockchain Instanodes is throwing down the gauntlet for the blockchain crowd as the field of quantum computing edges ever closer to unsettling the cryptographic order. This company's latest play? Post-quantum account engineering for major players like Ethereum and Solana. And it's not just tinkering—they're giving the status quo a...

Continue Reading

Top 5 Most Recently Viewed Articles

MindMaze Therapeutics: 2026 Business Update and Insights

Updated Category News Views 16

Breaking Down MindMaze’s 2026 Update Today, I’m sifting through MindMaze Therapeutics' latest half-year report like a prospector panning for gold nuggets. It’s a mixed bag, folks, full of expansion optimism underlined by a nagging loss in the financial ledger. But they say fortune favors the bold, right? The company has ambitious ideas, and their genetic makeup...

Continue Reading
Tantrum Sportfishing Celebrates Record Blue Marlin Achievement

Updated Category News Views 190

Historic Milestone for Tantrum Sportfishing In an inspiring turn of events for the sportfishing community, Tantrum Sportfishing has achieved a remarkable milestone. The Kona-based charter company announced its proud entry into the illustrious "Grander Club" after landing a colossal 1,039-pound Blue Marlin. This catch not only signifies a personal triumph for the team but...

Continue Reading
New Bitcoin ETF Offers Investors Unique Downside Protection

Updated Category News Views 227

Calamos Introduces a Groundbreaking Bitcoin ETF Investment management firm Calamos is excited to roll out an innovative approach to cryptocurrency investing with the launch of the world’s first 100% downside-protected Bitcoin exchange-traded fund (ETF). This launch comes just after an announcement suggesting that an ETF will be available for investors looking to...

Continue Reading
Exciting Developments in dsm-firmenich's Share Repurchase Initiative

Updated Category News Views 178

Progress Update on dsm-firmenich's Share Repurchase Program dsm-firmenich, known for its innovative approach in the fields of nutrition, health, and beauty, is actively implementing its large-scale share repurchase program. This initiative began earlier this year and signifies a strategic move to enhance shareholder value and manage capital effectively. Initial...

Continue Reading
Capricor Therapeutics: Key Deadlines for Shareholders to Remember

Updated Category News Views 133

Crucial Dates for Capricor Therapeutics Shareholders The Gross Law Firm has released an important notice for shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR). The firm encourages anyone who purchased shares during the specified class period to connect with them regarding possible lead plaintiff appointments. Being appointed as the lead plaintiff isn't necessary...

Continue Reading